Clinicopathological Characteristics and Outcomes of Lupus Nephritis Patients With Thrombocytopenia: A Single‐Center Retrospective Study
Immunity, Inflammation and Disease · 2025
DOI: 10.1002/iid3.70179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2025. Verfasst von Hui Diao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Lupus Nephritis, Thrombocytopenia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by grants from the National Natural Science Foundation of China (No. 81970599, 82170737); Key Laboratory of National Health Commission,…, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
The objective of this study is to analyze and summarize the clinical characteristics and prognosis of lupus nephritis (LN) patients with thrombocytopenia and to improve the cognition of the disease.
Methods
896 LN patients were enrolled in this study and their clinical and pathological data were collected and analyzed. The primary end point was mortality. The secondary end point was adverse renal outcomes, defined as doubling of the baseline serum creatinine or end‐stage renal diseases. Cox regression model was used to analyze the risk factors of mortality or renal events in LN with and without thrombocytopenia.
Results
Among 896 LN patients, 70 (7.8%) were diagnosed with thrombocytopenia. LN patients with thrombocytopenia had lower estimated glomerular filtration rate (eGFR) and higher systemic lupus erythematosus disease activity index (SLE‐DAI), proportion of anemia, leukopenia, hypocomplementemia, and positive anti‐cardiolipin antibodies, compared to those without thrombocytopenia. LN patients with thrombocytopenia had higher scores of activity index and more activity features (endocapillary hypercellularity, medullary loop necrosis) on kidney biopsy. There was no significant difference in patient survival and renal survival between LN patients with and without thrombocytopenia. Anemia was a risk factor for death in LN patients with thrombocytopenia and lower eGFR was a risk factor for adverse renal outcomes.
Conclusions
LN patients with thrombocytopenia showed higher disease activity, more anti‐cardiolipin antibody positivity and a higher activity index in kidney biopsy, but the prognosis was similar compared with those without thrombocytopenia. Anemia was a risk factor for death in LN patients with thrombocytopenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
- NHC Key Laboratory of Clinical Nephrology (Sun Yat-Sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China.
ORCID-Profile: Wei Chen
Förderung
- This work was supported by grants from the National Natural Science Foundation of China (No. 81970599, 82170737); Key Laboratory of National Health Commission,…
- National Natural Science Foundation of China
Zitieren
APA
Diao, H., Fan, Y., Kang, D., Chen, Z., Lu, Y., Huang, X., Xia, X., & Chen, W. (2025). Clinicopathological Characteristics and Outcomes of Lupus Nephritis Patients With Thrombocytopenia: A Single‐Center Retrospective Study. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70179
Vancouver
Diao H, Fan Y, Kang D, Chen Z, Lu Y, Huang X, et al. Clinicopathological Characteristics and Outcomes of Lupus Nephritis Patients With Thrombocytopenia: A Single‐Center Retrospective Study. Immunity, Inflammation and Disease. 2025. doi:10.1002/iid3.70179
BibTeX
@article{Diao2025,
author = {Diao, Hui and Fan, Yuting and Kang, Di and Chen, Zhiqing and Lu, Yuewen and Huang, Xiamin and Xia, Xi and Chen, Wei},
title = {Clinicopathological Characteristics and Outcomes of Lupus Nephritis Patients With Thrombocytopenia: A Single‐Center Retrospective Study},
journal = {Immunity, Inflammation and Disease},
year = {2025},
doi = {10.1002/iid3.70179}
}
EUVIMED